Tellimer

IN : Havells India Ltd - Balanced performance across segments

Market share gains continue all through FY21, with ECD leading from the front. Input cost inflation a worry; 4QFY21 gross/EBITDA margins decline qoq. Remain positive on structural recovery. Prolonged COVID-19 infections key downside risk. Maintain Add rating with a lower TP of Rs1,174.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers